of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia


Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia


Kabra A, Suresh KR, Vivekanand V, et al (Bhagwan Mahavir Jain Hosp, Bangalore, India) J Vasc Surg 57:44-49, 2013§



K. Hughes, MD



Evidence Ranking


B



Expert Rating


2



Abstract





Results


In the study, 81.2% of patients had forefoot ischemia, 17.2% had ischemic heel, whereas 1.6% had midfoot nonhealing ischemic ulceration. The runoff involved the anterior tibial artery in 42.2% (27/64), posterior tibial artery in 34.4% (22/64), and the peroneal artery in 23.4% (15/64). All patients were followed at 1, 3, and 6 months postoperatively for ulcer healing, major amputation, or death. At the end of 6 months, nine patients expired, and six were lost to follow-up. Of 49 patients who completed 6 months, nine underwent major amputation, and 40 had limb salvage. Ulcer healing at 1, 3, and 6 months for DR vs IR were 7.9% vs 5%, 57.6% vs 12.5%, and 96.4% vs 83.3%, respectively. This difference in the rates of ulcer healing between the DR and IR groups was statistically significant (P = .021). The limb salvage in the DR group (84%) and IR group (75%) was not statistically significant (P = .06). The mortality was 10.2% for DR and 20% for IR at 6 months.

Stay updated, free articles. Join our Telegram channel

Apr 3, 2017 | Posted by in CARDIOLOGY | Comments Off on of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access